Literature DB >> 9354467

Minors held by majors: the H13 minor histocompatibility locus defined as a peptide/MHC class I complex.

L M Mendoza1, P Paz, A Zuberi, G Christianson, D Roopenian, N Shastri.   

Abstract

The products of minor histocompatibility (H) loci are serious barriers to tissue transplantation even among major histocompatibility complex (MHC) identical individuals, frequently causing chronic graft rejection and graft versus host disease. Over 50 minor H loci map to mouse autosomal chromosomes but none are known at the molecular level. By expression cloning, we identified the H13 locus, a classical minor H locus first detected 30 years ago by the trait of graft rejection. The H13a allele is located on chromosome 2 and encodes a novel protein that yields the rare naturally processed nonapeptide SSVVGVWYL (SVL9) for presentation by the Db MHC class I molecule. The SVL9 peptide binds Db MHC despite the absence of the consensus binding motif, and a conservative methyl group substitution (Valine 4 <--> Isoleucine) explains why reciprocal T cell responses are elicited in H13a and H13b congenic strains.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9354467     DOI: 10.1016/s1074-7613(00)80368-4

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  23 in total

1.  A single nucleotide polymorphism in the Emp3 gene defines the H4 minor histocompatibility antigen.

Authors:  Brianna Luedtke; Laura M Pooler; Eun Young Choi; Angela M Tranchita; Corbett J A Reinbold; Aaron C Brown; Daniel J Shaffer; Derry C Roopenian; Subramaniam Malarkannan
Journal:  Immunogenetics       Date:  2003-07-04       Impact factor: 2.846

2.  Sensitization to minor antigens is a significant barrier in bone marrow transplantation and is prevented by CD154:CD40 blockade.

Authors:  H Xu; Y Huang; L R Hussain; Z Zhu; L D Bozulic; C Ding; J Yan; S T Ildstad
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

3.  Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells.

Authors:  Nicolas Blanchard; Takayuki Kanaseki; Hernando Escobar; Frédéric Delebecque; Niranjana A Nagarajan; Eduardo Reyes-Vargas; David K Crockett; David H Raulet; Julio C Delgado; Nilabh Shastri
Journal:  J Immunol       Date:  2010-02-19       Impact factor: 5.422

4.  Major histocompatibility complex class I-mediated inhibition of neurite outgrowth from peripheral nerves.

Authors:  Zhongqi-Phyllis Wu; Tina Bilousova; Nathalie Escande-Beillard; Hoa Dang; Terry Hsieh; Jide Tian; Daniel L Kaufman
Journal:  Immunol Lett       Date:  2010-10-23       Impact factor: 3.685

5.  Recognition of allo-peptide is governed by novel anchor imposition and limited variations in TCR contact residues.

Authors:  Corbett J A Reinbold; Subramaniam Malarkannan
Journal:  Mol Immunol       Date:  2007-11-05       Impact factor: 4.407

6.  Distributions of single nucleotide polymorphisms in differential chromosome segments of congenic resistant strains that define minor histocompatibility antigens.

Authors:  Peter J Wettstein; Nancy D Borson
Journal:  Immunogenetics       Date:  2007-05-31       Impact factor: 2.846

7.  The contributions of mass spectrometry to understanding of immune recognition by T lymphocytes.

Authors:  Victor H Engelhard
Journal:  Int J Mass Spectrom       Date:  2007-01-01       Impact factor: 1.986

8.  Pooling and PCR as a method to combat low frequency gene targeting in mouse embryonic stem cells.

Authors:  A C Brown; C P Lerner; J H Graber; D J Shaffer; D C Roopenian
Journal:  Cytotechnology       Date:  2006-11-02       Impact factor: 2.058

9.  Major and minor histocompatibility antigens to NIMA: Prediction of a tolerogenic NIMA effect.

Authors:  Masahiro Hirayama; Eiichi Azuma
Journal:  Chimerism       Date:  2011-01

10.  Neurons preferentially respond to self-MHC class I allele products regardless of peptide presented.

Authors:  Nathalie Escande-Beillard; Lorraine Washburn; Dan Zekzer; Zhongqi-Phyllis Wu; Shoshy Eitan; Sonja Ivkovic; Yuxin Lu; Hoa Dang; Blake Middleton; Tina V Bilousova; Yoshitaka Yoshimura; Christopher J Evans; Sebastian Joyce; Jide Tian; Daniel L Kaufman
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.